Home > News > pSivida to gets approval to test cancer cure on humans
April 26th, 2004
pSivida to gets approval to test cancer cure on humans
Abstract:
Global nanotechnology company pSivida Limited (PSD) today announced that its Singapore subsidiary has obtained all the necessary approvals to commence Phase IIa human clinical trials for its lead brachytherapy product, BrachySilT. The 12 week trial is scheduled to commence in May and will be conducted by Singapore’s National Cancer Centre (“NCC”).
Source:
egoli
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||